Opko
Opko Health Posts 19 Percent Drop in Q4 Revenues on COVID-19 Testing Decline
Despite the revenue fall, which was largely driven by a continued slide in COVID-19 testing volume, Opko topped Wall Street analysts' consensus estimate.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.
JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More
Highlights of the third day included Quantum-Si's plans for its protein sequencing platform and strategic initiatives from Opko's BioReference Laboratories.
Opko Health Q3 Revenues Fall 10 Percent
Despite decreases in COVID-19 testing volume, the firm saw an increase in clinical and genomic test revenue.
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Mar 10, 2017
Oct 10, 2016
May 9, 2016